Chemistry Reference
In-Depth Information
Table 2.1
(
Continued
)
Method of
Characterization
Compound
1
preparation
2
techniques
3
Reference
1
H,
13
C,
89
Y
[Y
OR
3
]
2
R D CMe
2
Pr
i
,CMeEtPr
i
,CEt
3
I
IR;
345
NMR; MS
IR;
1
H,
13
CNMR;
X-ray
[Y
OC
2
H
4
OMe
3
]
10
A
57
[La
3
OBu
t
9
HOBu
t
2
]
I
1
H,
13
CNMR;MS;
X-ray
345
1
H,
13
C NMR; MS
[La
OR
3
]
2
R D CMe
2
Pr
i
,CMeEtPr
i
I
345
[La
3
OBu
t
9
thf
2
]
E-2
1
H,
13
CNMR;
X-ray
160
IR;
1
H,
13
CNMR;
X-ray
[La
OCPh
3
3
]
2
I
346
[LafOCMe
CF
3
2
g
3
thf
3
]
I
IR;
1
H,
13
CNMR;
MS; X-ray
349c
La
4
OCH
2
Bu
t
12
IR;
1
H,
13
CNMR;
X-ray
I
348a
[Ce
OPr
i
4
.
Pr
i
OH]
2
E-1
MW
143
1
H,
13
CNMR;
X-ray
E-2
460
Ce
OCBu
t
3
3
I
MW
344
[Ce
OCHBu
t
2
3
]
2
150
Ž
C, vacuum
X-ray
344
Ce
OR
4
R D Me, Et, Pr
n
,Bu
n
,Bu
i
,
CH
2
Bu
t
G
MW
143
Ce
OBu
t
4
thf
2
E-2
IR;
1
H,
13
C NMR
164
[PrfOCMe
CF
3
2
g
3
NH
3
2
]
2
I
IR; MS; X-ray
349
1
H NMR; X-ray
[PrfOCMe
CF
3
2
g
3
NH
3
4
]
I
IR;
349b
[PrfOCMe
2
CF
3
g
3
]
3
I
IR; MS; X-ray
349
[Nd
OCBu
t
3
3
thf
]
I
IR;
1
H NMR; X-ray
959
Nd
4
OCH
2
Bu
t
12
1
H NMR; X-ray
I
IR;
348a
Nd
2
OCHPr
i
2
6
thf
2
I
IR;
1
H NMR; X-ray
348
[Nd
OPr
i
3
.
Pr
i
OH]
4
A
IR
56
[EufOCMe
CF
3
2
g
3
]
n
I
IR
349b
[Eu
2
fOCMe
CF
3
2
g
6
NH
3
2
]
I
IR
349b
[EufOCMe
CF
3
2
g
3
thf
3
]
1
H,
19
F NMR; MS
I
349c
1
H,
19
F NMR; MS
[EufOCMe
CF
3
2
g
3
diglyme
]
I
349c
IR;
1
H,
13
CNMR;
MS; X-ray
[Lu
OCMe
2
CH
2
OMe
3
]
2
I
355
Actinides
[Th
OPr
i
4
]
n
E-2
MW
141
[Th
OEt
4
]
n
G
MW
141
[Th
OR
4
]
n
G
MW
143
R D Bu
n
,Pent
n
,CH
2
Bu
t
143
R D CMe
3
,CMe
2
Et, CMeEt
2
,
CMe
2
Pr
n
,CMe
2
Pr
i
,CEt
3
,
CMeEtPr
n
, CMeEt,Pr
i
141a
Th
4
OPr
i
16
Py
2
IR;
1
H,
13
CNMR;
X-ray
E-2
165
IR;
1
H,
13
CNMR;
X-ray
Th
2
OCHEt
2
8
Py
J-3
165
[Th
OBu
t
4
Py
2
]
1
H NMR; X-ray
E-2
IR;
398
